RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
FDA Approves Tecentriq Immunotherapy for Specific Type of Advanced Lung Cancer. The U.S. Food and Drug Administration (FDA) approved Genentechâs Tecentriq (atezolizumab) as a treatment for people with metastatic non-small cell lung cancer (NSCLC).
Brand name: TecentriqÂ®. Atezolizumab is approved to treat urothelial carcinoma, the most common type of bladder cancer. Atezolizumab is a checkpoint inhibitor, an immunotherapy drug designed to target the PD-L1 protein on cancer cells. Cancer cells are able to use PD-L1 to send signals to the PD-1 protein on immune cells, tricking the immune cells into recognizing the cancer cells as normal.